Surgery News and Research

RSS

Androgen deprivation therapy lowers satisfaction after penile prosthesis surgery

Prostate cancer is the most common malignancy among men, with over 160,000 new cases diagnosed annually in the United States.

1 Sep 2025

Exploring testosterone's influence on cardiovascular, metabolic, reproductive, and mental health

For decades, testosterone has been recognized as the primary driver of male reproductive development and secondary sex characteristics.

1 Sep 2025

Cancer-related nerve injury triggers inflammation and immunotherapy resistance

Cancer cells can break down the protective covers around nerves, causing nerve injury that triggers chronic inflammation leading to immune exhaustion and eventual resistance to immunotherapy, according to new research from The University of Texas MD Anderson Cancer Center.

1 Sep 2025

Study provides evidence for a causal genetic link between prostate cancer and urothelial carcinoma

Prostate cancer is among the most common cancers in men and a leading cause of cancer-related deaths. With improved detection and therapies, survival rates have risen, but this progress comes with a new concern: the risk of secondary primary malignancies.

1 Sep 2025

Shorter dual antiplatelet therapy may offer safety benefits in myocardial infarction patients

Three months of dual antiplatelet therapy (DAPT) was associated with signals suggesting improved survival and lower bleeding risk than 12 months of DAPT, in a real-world all-comer population of patients with myocardial infarction (MI), according to late-breaking research presented in a Hot Line session today at ESC Congress 2025.

1 Sep 2025

Ivabradine fails to prevent myocardial injury after noncardiac surgery in large clinical trial

Ivabradine did not reduce the occurrence of myocardial injury after noncardiac surgery (MINS), according to late-breaking research presented in a Hot Line session today at ESC Congress 2025.

1 Sep 2025

Extended apixaban therapy lowers recurrent VTE in patients with provoked events and enduring risk factors

Apixaban 2.5 mg twice daily significantly reduced symptomatic venous thromboembolism (VTE) recurrence, with a low risk of major bleeding, in patients with provoked VTE and enduring risk factors, according to late-breaking research presented in a Hot Line session today at ESC Congress 2025 and simultaneously published in New England Journal of Medicine.

1 Sep 2025

Updated guidelines aim to standardize valvular heart disease care across Europe

Updated ESC/EACTS Guidelines, being published today at ESC Congress 2025, aim to improve the way that patients with valvular heart disease are diagnosed and treated, responding to robust new evidence that suggests some newer and less invasive treatments could be offered more widely and consistently to patients.

30 Aug 2025

New ESC guidelines introduce unified approach to improve myocarditis and pericarditis care

New ESC Guidelines to improve the diagnosis and care of patients with myocarditis and pericarditis, have been published today at ESC Congress 2025.

30 Aug 2025

REBOOT trial finds no benefit of beta blockers after uncomplicated heart attacks

Beta blockers-drugs commonly prescribed for a range of cardiac conditions, including heart attacks-provide no clinical benefit for patients who have had an uncomplicated myocardial infarction with preserved heart function.

30 Aug 2025

What are the benefits of chewing gum beyond oral health?

Chewing gum offers health benefits beyond oral care, enhancing performance and recovery, but research gaps for children and seniors need addressing.

29 Aug 2025

Sinus surgery proves more effective than antibiotics for chronic rhinosinusitis

Sinus surgery is more effective than antibiotics at treating chronic rhinosinusitis, according to a major clinical trial led by University College London (UCL) along with academics at the University of East Anglia and Guy's and St Thomas' NHS Foundation Trust.

28 Aug 2025

UC San Diego Health performs world’s first personalized spine surgery

UC San Diego Health is the first health system in the world to perform an anterior cervical spine surgery using a fully personalized implant designed for a patient's unique anatomy.

28 Aug 2025

Study brings hope for a more personalized approach to treat ER+ breast cancer

A new study from researchers at Baylor College of Medicine brings hope for a more personalized approach to treat estrogen receptor-positive (ER+) breast cancer, the most common type of this cancer.

28 Aug 2025

New imaging method detects colorectal cancer using tissue autofluorescence

Colorectal cancer (CRC) is one of the most common and deadly forms of cancer worldwide. A key reason for its high death toll is that it often goes undetected until it reaches an advanced stage.

28 Aug 2025

New swallowable device enables noninvasive gut nerve stimulation

Scientists have long struggled with how to study the gut's vast nervous system - often called the body's 'second brain' - without damaging it.

28 Aug 2025

Study finds minimal risk of second cancer in breast cancer survivors

For women diagnosed with early breast cancer, the long-term risk of developing a second primary cancer is low (around 2-3% greater than women in the general population), finds a study published by The BMJ today.

28 Aug 2025

Longitudinal study reveals how GLP-2 analog therapy transforms the intestinal environment

Researchers from Japan discover that glucagon-like peptide-2 (GLP-2) analogs can deeply and beneficially reshape the intestinal environment.

27 Aug 2025

Increasing numbers of bariatric surgery patients turn to GLP-1 drugs

Bariatric surgery is usually effective on its own for weight loss, but an increasing proportion of patients who undergo bariatric surgery start taking one of the new glucagon-like 1 peptide receptor agonist (GLP-1) weight-loss drugs in the years after their surgery, according to a new study led by researchers at the Johns Hopkins Bloomberg School of Public Health.

27 Aug 2025

Regenerative strategy offers hope for women with pelvic organ prolapse

Pelvic organ prolapse (POP) is a disorder that primarily affects older women who have experienced multiple vaginal childbirths.

27 Aug 2025

Previous
1
...
62
63
64
65
66
67
68
...
1693
Next

Surgery News and Research

Androgen deprivation therapy lowers satisfaction after penile prosthesis surgery

Exploring testosterone's influence on cardiovascular, metabolic, reproductive, and mental health

Cancer-related nerve injury triggers inflammation and immunotherapy resistance

Study provides evidence for a causal genetic link between prostate cancer and urothelial carcinoma

Shorter dual antiplatelet therapy may offer safety benefits in myocardial infarction patients

Ivabradine fails to prevent myocardial injury after noncardiac surgery in large clinical trial

Extended apixaban therapy lowers recurrent VTE in patients with provoked events and enduring risk factors

Updated guidelines aim to standardize valvular heart disease care across Europe

New ESC guidelines introduce unified approach to improve myocarditis and pericarditis care

REBOOT trial finds no benefit of beta blockers after uncomplicated heart attacks

What are the benefits of chewing gum beyond oral health?

Sinus surgery proves more effective than antibiotics for chronic rhinosinusitis

UC San Diego Health performs world’s first personalized spine surgery

Study brings hope for a more personalized approach to treat ER+ breast cancer

New imaging method detects colorectal cancer using tissue autofluorescence

New swallowable device enables noninvasive gut nerve stimulation

Study finds minimal risk of second cancer in breast cancer survivors

Longitudinal study reveals how GLP-2 analog therapy transforms the intestinal environment

Increasing numbers of bariatric surgery patients turn to GLP-1 drugs

Regenerative strategy offers hope for women with pelvic organ prolapse

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News